Results 1 to 10 of about 9,743 (171)

HEREDITARY HEMORRHAGIC TELANGIECTASIA

open access: yesVision Pan-America, 2015
We describe a patient with clinical history of intermittent haemolacria associated to hereditary hemorrhagic telangiectasia, first seen and diagnosed by the ophthalmologist.
Messody Zagury   +5 more
doaj   +9 more sources

Stroke in hereditary hemorrhagic telangiectasia patients. New evidence for repeated screening and early treatment of pulmonary vascular malformations: two case reports [PDF]

open access: yesBMC Neurology, 2011
Background Paradoxical embolism due to pulmonary arteriovenous malformations is the main mechanism of brain infarction in patients with hereditary hemorrhagic telangiectasia.
Viader Fausto   +4 more
doaj   +3 more sources

Hereditary Hemorrhagic Telangiectasia

open access: yesPediatric Neurology Briefs, 1998
Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu disease, was the subject of an NIH workshop, organized by the National Heart, Lung, and Blood Institute, on July 10-11, 1997.
J Gordon Millichap
doaj   +4 more sources

Beyond epistaxis: cascade screening and presymptomatic treatment of hereditary hemorrhagic telangiectasia [PDF]

open access: yesBMC Pediatrics
Background Hereditary Hemorrhagic Telangiectasia is an autosomal dominant vascular disorder with clinical features of recurrent epistaxis, mucocutaneous telangiectasias, or visceral arteriovenous malformations, yet its early signs may be overlooked in ...
Chen Xiang Ang   +2 more
doaj   +2 more sources

Epistaxis due to hereditary hemorrhagic telangiectasia: A case report and literature review [PDF]

open access: yesJournal of International Medical Research
Characterized by abnormalities of the blood vessel wall, hereditary hemorrhagic telangiectasia is an autosomal dominant disorder. Recurrent or spontaneous epistaxis is the most prevalent symptom of hereditary hemorrhagic telangiectasia, whose severity ...
Xiangnan Du   +3 more
doaj   +2 more sources

Optimal management of hereditary hemorrhagic telangiectasia [PDF]

open access: yesJournal of Blood Medicine, 2014
Neetika Garg,1 Monica Khunger,2 Arjun Gupta,3 Nilay Kumar4 1Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA; 2Department of Medicine, All India Institute of Medical Sciences, New Delhi, India; 3Department of Medicine, UT ...
Garg N, Khunger M, Gupta A, Kumar N
doaj   +3 more sources

P- 18 TREATMENT WITH BEVACIZUMAB IN HIGH OUTPUT CARDIAC FAILURE DUE TO SEVERE HEPATIC COMPROMISE IN HEREDITARY HEMORRHAGIC TELANGIECTASIA PATIENTS: OBSERVATIONAL COHORT STUDY

open access: yesAnnals of Hepatology, 2023
Introduction and Objectives: Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant vascular dysplasia affecting 1/5000 individuals. Epistaxis, mucocutaneous telangiectasias and vascular malformations affecting internal organs (brain, lungs,
Carolina Vazquez   +2 more
doaj   +1 more source

Hereditary hemorrhagic telangiectasia [PDF]

open access: yesCanadian Medical Association Journal, 2009
Hereditary hemorrhagic telangiectasia, or Osler–Weber–Rendu syndrome, is an autosomal dominant vascular disorder that affects multiple systems. It is characterized by skin and mucosal telangiectasias and arteriovenous malformations. In 1876, Sir John Legg described a case of “hemophilia”
Dieter Metze   +199 more
openaire   +3 more sources

Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets. [PDF]

open access: yes, 2014
BackgroundPulmonary first pass filtration of particles marginally exceeding ∼7 µm (the size of a red blood cell) is used routinely in diagnostics, and allows cellular aggregates forming or entering the circulation in the preceding cardiac cycle to lodge ...
AD Kjeldsen   +83 more
core   +9 more sources

Home - About - Disclaimer - Privacy